Vimta Labs (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039
|
Vimta Labs Limited |
|||
|
Price: ₹993.05 | ||
| 52 Week Low: ₹399.70 52 Week High: ₹1,069.95 |
|||
| Market Capital: 1,105.09 Crore (Smallcap) | |||
| Healthcare -> Diagnostics & Research | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Vimta Labs Share Price Target For 2024
- 1.1.1: Vimta Labs Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Vimta Labs Share Price Target For 2025
- 1.2.1: Vimta Labs Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Vimta Labs Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Vimta Labs Brief Company Overview
- 4: Vimta Labs Financial Performance
- 4.0.1: Is Vimta Labs A Good Buy For Long Term?
To predict the Vimta Labs's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Vimta Labs Share Price Target For 2024
The line chart displays the monthly closing prices of Vimta Labs with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Vimta Labs shares in 2024, see the table below.
Vimta Labs Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 1054.0 (+6.13%) | Price Action: 17 Dec 2024 High |
| 2024 Target 2 | 1037.05 (+4.43%) | Fibonacci Extension Level 23.60% |
| 2024 Target 1 | 1024.0 (+3.11%) | Price Action: 19 Dec 2024 High |
| Current Price | 993.05 | Vimta Labs's share price as of 23 Dec 2024 |
| Stop Loss 1 | 979.45 (-1.37%) | Price Action: 16 Dec 2024 High |
| Stop Loss 2 | 965.0 (-2.83%) | Price Action: 13 Dec 2024 High |
| Stop Loss 3 | 953.35 (-4%) | Price Action: 23 Dec 2024 Low |
Short-Term Technical Outlook
Current Technical Position: Vimta Labs is showing bullish momentum with price above both 25-day and 50-day moving averages.
Key Technical Level: The 25-day moving average at ₹905.07 serves as the nearest technical reference point.
Historical Returns: 3-month: +77.12% | 6-month: +103.18% | 1-year: +139.3%
Vimta Labs Share Price Target For 2025
The line chart displays the monthly closing prices of Vimta Labs with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Vimta Labs shares in 2025, see the table below.
Vimta Labs Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 1462.41 (+47.26%) | Price Action: Chart |
| 2025 Target 2 | 1435.14 (+44.51%) | Fibonacci Extension Level 64.90% |
| 2025 Target 1 | 1410.54 (+42.04%) | Fibonacci Extension Level 150.00% |
| Current Price | 993.05 | Vimta Labs's share price as of 23 Dec 2024 |
| Stop Loss 1 | 892.0 (-10.18%) | Price Action: 05 Dec 2024 Low |
| Stop Loss 2 | 876.59 (-11.73%) | Price Action: 28 Nov 2024 Low |
| Stop Loss 3 | 863.04 (-13.1%) | Price Action: 27 Nov 2024 Low |
Long-Term Technical Outlook
52-Week Range Analysis: Vimta Labs is currently trading near its 52-week high of ₹1069.95, showing strong yearly momentum.
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: +139.3% | 3-year: +138.71% | 5-year: +961.23%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Vimta Labs Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹993.05 | ||
| 2024 | ₹652.84 | -34.25% | ₹662.63 |
| 2025 | ₹1,064.46 | +63.05% | ₹1,080.43 |
| 2026 | ₹1,478.09 | +38.85% | ₹1,500.26 |
| 2027 | ₹1,961.75 | +32.72% | ₹1,991.18 |
| 2028 | ₹2,024.96 | +3.22% | ₹2,055.33 |
| 2029 | ₹2,210.67 | +9.17% | ₹2,443.01 |
| 2030 | ₹2,783.91 | +25.93% | ₹2,924.27 |
| 2031 | ₹3,282.68 | +17.91% | ₹3,405.53 |
| 2032 | ₹3,886.79 | +18.4% | ₹3,945.09 |
| 2033 | ₹3,686.03 | -5.16% | ₹3,741.32 |
| 2034 | ₹3,768.50 | +2.23% | ₹4,368.06 |
| 2035 | ₹4,503.37 | +19.5% | ₹4,849.32 |
| 2036 | ₹5,087.27 | +12.96% | ₹5,330.58 |
| 2037 | ₹5,811.84 | +14.24% | ₹5,899.02 |
| 2038 | ₹5,347.10 | -7.99% | ₹5,538.42 |
| 2039 | ₹5,233.08 | -2.13% | ₹6,293.10 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Vimta Labs Brief Company Overview
Vimta Labs Limited: A Leader in Contract Research and Testing Services Since its inception in 1984, Vimta Labs Limited has established itself as a reputable provider of contract research and testing services in India and globally. The company's comprehensive range of...
services caters to diverse industries, including agriculture, pharmaceuticals, medical devices, nutraceuticals, and environmental testing. Its solutions encompass drug life cycle management, preclinical and clinical research, bioanalytical and analytical services, and various testing capabilities. Vimta Labs Limited is committed to providing accurate and reliable data, ensuring the safety and efficacy of products across various industries.Vimta Labs Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 1,105.09 Crore | Market valuation of Vimta Labs's shares. |
| Revenue (TTM) | 321.24 Crore | Total revenue generated by Vimta Labs over the past twelve months. |
| Net Income (TTM) | +41.34 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +16.09% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +12.86% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+5.6% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
-1.1% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
6.51 | Company's total debt divided by total shareholder equity. |
| Total Debt | 19.31 Crore | Sum of Vimta Labs's current & long-term financial obligations. |
| Total Cash | 26.16 Crore | Total amount of liquid funds available to Vimta Labs. |
| Beta | 0.76 | Beta is less than 1 indicating that the Vimta Labs's price is less volatile than the market. |
Is Vimta Labs A Good Buy For Long Term?
Vimta Labs' revenue growth and profitability have been moderate. Its debt levels are manageable, and it has a positive cash balance. The stock has delivered significant returns over the past three and five years. While the company's earnings declined in the recent quarter, its long-term growth prospects appear promising. Based on the available data, Vimta Labs can be considered an average buy for long-term investors seeking potential growth in the small-cap segment.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
